Printer Friendly

Diabetes distress scale-17 implementation among patients with diabetes: Turkish validity and reliability study.

Byline: Goksen Erkin, Kurtulus Ongel, Haluk Mergen, Tevfik Tanju Yilmazer and Berna Erdogmus Mergen

Abstract

Objective: To prove reliability and validity of the Turkish version of diabetes distress scale.

Methods: The cross-sectional study was conducted at Tepecik Training and Research Hospital, Izmir, Turkey, from July 2011 to February 2012, and comprised diabetics whose ages ranged from 25 to 86 years who voluntarily participated in the study. Descriptive statistics, exploratory and confirmatory factor analyses were used for reliability and validity evaluations. SPSS 21 was used for data analysis.

Results: Of the 165 patients, 87(52.7%) were women and 78(47.3%) were men. Overall, 32(19.4%) patients had normal weight, 52(31.5%) were overweight, 74(44.8%) were obese and 7(4.2%) were morbid obese. Mean age was 53.6911.39 years. Mean score was 50.8711.53 points (range: 23 to 84). As for distress distribution, 15(9.1%) patients had no problem (0-34 points), 141(85.5%) moderate (35-68 points) and 9(5.5%) had high (>68 points).Fasting blood glucose was higher than 200 mg/dl in 22(13.2%) patients.

Conclusion: Turkish diabetes distress scale-17 was found to be valid and reliable and had satisfying fit-index parameters.

Keywords: Diabetes, Distress, Validity, Reliability. (JPMA 66: 662; 2016)

Introduction

Diabetes Mellitus (DM) is a metabolic and endocrinologic disease originating from lack of insulin and/or impairment of effect or both.1 It is a metabolic disorder with chronic progress,2,3 and causes complications in eyes, kidneys, nervous system, cardiac and vascular bed. Moreover, it could decrease life quality and life expectancy. Turkey is estimated to have more than six million diabetics. According to Turkish DM epidemiology research (TURDEP-II), the prevalence of DM was 13.7% and nearly 27% for the patients with impaired glucose tolerance (IGT) or pre-DM.4,5

Preclinical DM risk factors include familial DM history, cardiovascular disease (CVD), excess weight (body mass index [BMI]>25kg/m2), sedentary lifestyle, previous impaired fasting glucose (IFG) and IGT, hypertension (HT) (>140/90 mmHg), hypertriglyceridemia (>250 mg/dl) and/or low high- density lipoprotein (HDL) (less than 35mg/dl), gestational DM history, giving birth to a baby weighing 4kg or above, polycystic ovary syndrome (PCOS)and age over 45 years.6,7

DM is an endocrinologic chronic disease with the psychosociological dimensions affecting all aspects of life.8 It has chronic complications causing serious morbidity and mortality, great cost to the patient and to population, and negatively affects physical, psychological health and the inner vision of the patient.8 DM shows comorbidity with depression and anxiety disorders.3,9-21

This current study was planned to prove the reliability and validity of the 17-item diabetes distress scale (DDS17) by exploring patients' distresses and insights.

Patients and Methods

The cross-sectional study was conducted between July 2011 and February 2012 in Tepecik Training and Research Hospital, Izmir, Turkey, and comprised DM patients. After permission from the institutional review board, the sample size was calculated at 95% confidence interval (CI) by "universe known sampling" formula.

Original English DDS17, constituted by Polonsky et al.,22 was adapted to Turkish language. The English text was translated into Turkish by two translators who had high grades in the English language proficiency examinations. The translated text was back-translated to English; level of accuracy was evaluated, the ambiguities were rechecked and adjustments were made.

Distress was calculated using 6-point Likert answers as follows: no problem (1, 2), medium (3, 4), and serious problem (5, 6). Patients participating in the study chose their convenient answers regarding their distress.

SPSS 21 was used for data analysis and for calculating internal consistency (reliability) Cronbach's alpha was used. Item-total correlation (rit) was used for content validity.

Exploratory and confirmatory factor analyses were used for validity analyses. Sociodemographic data was analysed by chi-square test; pless than 0.05 was considered significant.

Results

Out of the 165 patients, 87(52.7%) were women and 78(47.3%) were men. The overall mean age was 53.6911.39 years (range: 25-86 years), mean weight 82.7115.78kg (range: 49-142), mean height 165.7111.46cm (range: 72-194cm); and mean body mass index (BMI) was 30.016.05kg/m2 range: 18.93-68.82) (Table-1). Overall, 32(19.4%) patients had normal weight, 52 (31.5%) were overweight, 74 (44.8%) were obese and 7(4.2%) were morbid obese. Mean fasting blood glucose (FBG) was 149.2655.81mg/dl (range: 88-440). It was higher than 200 mg/dl in 22(13.2%) patients. Mean scale answer score was 50.8711.53 points (SD) (range: 23-84). As for distress distribution, 15(9.1%) patients had no problem (0-34 points), 141(85.5%) had moderate (35-68 points) and 9(5.5%) high (>68 points). Mean Pearson's rit coefficient was 0.2670.242.

The most frequent diseases relating to type 1 DM (T1DM) were: HT in 2(1.21%) patients, hyperlipidaemia (HL) in 2(1.21%) and no disease (only T1DM) in 2(1.21%); while those relating to T2DM were: HT in 38(23.03%) patients, HL in 32(19.40%), HT+HL in 63(38.18%), additional disease with/without HT and/or HL in 10(6.06%) and no disease (only T2DM) in 16(9.7%) patients.

Table-1: Sociodemographic data of the study population.

Sociodemographic data###n###%

Gender###Female###87###52.7

###Male###78###47.3

Education level###Illiterate###15###9.1

###Primary school###69###41.8

###Secondary school###46###27.9

###High school###27###16.4

###University Graduate###8###4.8

Occupation###Housewife###76###46.1

###Retired###33###20.0

###Worker###22###13.3

###Other###34###20.6

Monthly income###313-625$###52###31.5

###625-1250$###28###17

###>1250$###6###3.6

###Undetermined###19###11.5

###None###60###36.4

Table-2: Varimax rotated iterated principal exploratory factor analysis of DDS-17-Turkish.

###Factor 1###Factor 2###Factor 3###Factor 4###S Variance %

###(Emotional status)###(Physician)###(Interpersonal stress)###(Regimen)

Variance %###28.5###12.9###10.8###7.7###59.9

Item3###0.775###0.173###-0.014###0.015

Item14###0.763###0.149###0.243###0.015

Item1###0.746###0.121###0.071###0.054

Item8###0.729###-0.034###0.123###0.089

Item10###0.618###0.062###0.221###0.135

Item16###0.604###0.127###0.359###0.113

Item9###0.000###0.801###0.256###-0.045

Item2###0.093###0.758###0.156###-0.075

Item4###0.313###0.756###0.054###0.014

Item15###0.101###0.695###0.036###0.111

Item13###0.271###0.173###0.804###0.077

Item17###0.201###0.126###0.766###-0.051

Item7###0.139###0.147###0.755###0.169

Item6###0.013###-0.019###0.023###0.872

Item12###0.157###-0.126###0.045###0.792

Item5###-0.121###0.292###0.135###0.585

Item11###0.216###-0.024###0.016###0.537

Cronbach's alpha value was 0.823 and rit was 0.221 (range: -0.117-0.633). Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.781, and Bartlett's sphericity test was significant (p=0.000). These two results allowed us to do factor analysis of DDS17-Turkish scale. According to principal component analysis by varimax rotation with Kaiser Normalisation, the Eigen values over 1 were: 4.844, 2.186, 1.838 and 1.307. Four factors were found to constitute 59.9% of the total variance. Item no.1, 3, 8, 10, 14 and 16 constitutedFactor1 explaining 28.5% of the total variance and it could be called 'emotional status'. Similarly, Factor 2 (items 2, 4, 9 and 15; 'physician stress') explained 12.9%, Factor 3 (items 7, 13 and 17; 'interpersonal stress') explained 10.8%, and Factor 4 (items 5, 6, 11, 12; 'compliance to regimen') explained 7.7% of the total variance (Table-2).

For the confirmatory factor analysis, the goodness of fit index (GFI) was 0.89, normed fit index (NFI) 0.94, comparative fit index (CFI) 0.96, 2=170.2, df=107, 2/df=1.59, p=0.0001, root mean square error of approximation (RMSEA) =0.060. The values confirmed that DDS-17-Turkish had a good-fit statistics (Figure).

Discussion

The measurement instruments of the distress of DM patients make it possible to quantify the patient's opinion regarding their disease, satisfaction and accessibility in dealing with this manner, and the treatment follows. However, in practice, there is a lack of reliable and sensitive measurement instruments. The adaptation of the present questionnaire was, in this aspect, very important, as it was an internationally- validated instrument that permitted us to make the comparison between different countries.

This study's demographic data corresponds to a DDS17 study performed by Fisher et al.23 In this study, 52.7% of the participants were women and 47.3% were men with a mean age of 53.6911.39. In Fisher et al.'s study, there were 57% women and 43% men with a mean age of 57.839.86. In the original DDS17study of Polonsky et al., there were no differences between gender, ethnicity, education level, duration of DM and total DDS 17 score.22 However, in this study, gender was found statistically significant with total DDS 17-Turkish score (2=4.459, df=1, p=0.030) so that women had higher score than men. Monthly income was also found statistically significant with total DDS17-Turkish score (2=16.99, df=8, p=0.030).

In the original study mean DDS17 score was 38.5 against this study's 50.8711.53. This could be due to lower monthly income, lower education level in Turkey and other stress factors (e.g. social security).

In this study, all women believed their DM would cause long-time serious health problems in the future (pless than 0.05). Obese patients trusted their physician for having enough knowledge of their illnesses (pless than 0.05). However, they believed they did not have enough emotional support from their families and friends (pless than 0.05).

Socioeconomic levels of the participants were lower while their mean FBG levels were higher than normal (pless than 0.05). Patients having high socioeconomic status thought they had enough emotional support from their families (pless than 0.05).

Patients with high FBG thought their illness would cause serious health problems for them. Depending on low level of socioeconomic status, higher level of basal BG could be found related with inexpensiveness of carbohydrate-based nutrition rather than protein-based nutrition.

In Citil et al.'s study, many factors like female gender, higher age, and lower education were affecting the HbA1c, long duration of DM, highness of BMI, additional chronic diseases.24

The most co-existing diseases were HT and HL. Moreover, Onder et al.'s study has depicted that HT frequency was found twice in DM patients rather than non-DMones, which concurs with our study's results. Coexistence of HT and HL with DM could be found related with metabolic syndrome prevalence in Turkish people because its frequency was 28% in men and 40% in women.25

No occupational factor was found affecting the insight of patients regarding their diseases.T1DM patients constituted 3.63% of the participants while T2DM (T2DM) constituted 96.37%, similar to the original study's population.21

Conclusion

DDS17-Turkish scale was valid and reliable, and had satisfying fit-index parameters. It could be implemented to Turkish DM patients. Further analyses with other instruments measuring anxiety and depression must be done for supporting this scale.

Acknowledgement

We are grateful to to Dr. Seref TAN for statistical assistance, especially for the analysis of confirmatory factor analysis of DDS-17-Turkish.

Disclosure: This article or part of this article has not been published in any other journal.

Conflict of Interest: None.

Financial Support: None.

References

1. Ilkova H. Diabetes Mellitus, Diagnosis, Epidemiology and Classification. In: Yazici H, Hamuryudan V, Sonsuz A. Istanbul MedikalYayincilik, eds. Cerrahpasa Internal Medicine Textbook. 1sted.Istanbul: 2005; pp 1086-90.

2. Wilding JPH. Obesity And Nutritional Factors.In: Pickup JC, Williams G, eds.Textbook of Diabetes.vol 1.Oxford: Blackwell Science, 2003; pp 21-16.

3. Nichols GA, Brown JB. Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care. 2003; 26: 744-9.

4. Yilmaz MT. New Vision, Target and Algorhythms in DM: DM 2020 Platform. [online] [cited2012July 19]. Available from: URL: http: //www.teb.org.tr/images/upld2/ecza_akademi/makale/2011011 3043248diyabette_yeni_vizyon.pdf

5. TURDEP-II Study Group(Turkey Diabetes Prevalence Study-II Summary).. [online] [cited 2012 July 19]. Available from: URL: http: //www.istanbul.edu.tr/itf/attachments/021_turdep.2.sonuclarini n.aciklamasi.pdf

6. American Diabetes Association. Standards of Medical Care in Diabetes-2012. Diabetes Care. 2012; 35 Suppl 1: S11-63.

7. National DM Congress Consensus Group. UDK Diabetes Diagnosis and Treatment Guide.Turkish Diabetes Association. 2011; 18-24.

8. Kirli S, Sarandol A. Diabetes Mellitus and Psychiatric Problems. In: ImamogluS. DeomedMedikalYayincilikeds, Diabetes Mellitus 2009 Diagnosis, Treatment and Prognosis by Multidisciplinary Approach. 3rded, Istanbul: 2009; 552-7.

9. ErenI, CiviO. Life quality and effect of complication to life in type IIdiabetes mellitus patients. KlinikPsikiyatriDergisi. 2004; 7: 85-94.

10. OzkanS.PscyhiatricAnd Psychosocial View To Diabetes. Psychiatric Medicine. Istanbul: Consultation-Liason Psychiatry, 1993.

11. ErenI, Erdi O, Ozcankaya R. Relationship Of Blood Glucose Control With Psychiatric Disorders In Patients with TypeIIDiabetes.Turk Psikiyatri Derg. 2003;14: 184-91.

12. Turhan H. Treatment Modality in Patients with Type 2 Diabetes Mellitus and Depression and Anxiety Disorders by Time. Taksim Training and Research Hospital. Turkish Ministry of Health, Family Medicine Thesis, Istanbul 2007.

13. Elbi H. Chronic Disease and Depression.EgeUniv KlinikPsikiyatri. 2008; 11: 3-18.

14. Bahar A, Sertbas G, SonmezA.Determination of Diabetes Mellitus Patients with Depression and Anxiety Levels. Anatolian J Psychiatr 2006; 7: 18-26.

15. Arabaci M, Cetinkaya K, Ors OP, OngelK.Showing Anxiety in Chronic Disease: A Case of Type 1 DM. 6thNational Anxiety Congress, Proceedings p.124-5, Girne-Kibris, September 9th-13rd, 2011.

16. Oguzhanoglu NK. Medical Conditions and Depression. Mood Series 2001; 3: 116-25.

17. Guven T. Investigation of Quality of Life in Patients with Diabetes Mellitus and Depression Effects. Turkish Ministry of Health, SisliEtfalTrainingand Research Hospital, Psychiatry Thesis, Istanbul: 2007.

18. Eren I, Erdi O. Effects of complications of Type 2 DM in Psychiatric Comorbidity. PsikiyatriPsikolojiPsikofarmakoloji (3P) Dergisi. 2004; 12: 209-16.

19. Ozdemir I, HocaogluC, Kocak M, ErsozHO.Quality of Life in Patients with Type 2 Diabetes Mellitus and Psychiatric Symptoms.Du?unen Adam: PsikiyatriveNorolojikBilimlerDergisi. 2011; 24: 128-38.

20. Onde ME, Ozcubukcuoglu A. Diabetes and Depression.KlinikPsikofarmakolojiBulteni. 1998; 8: 69-73.

21. Kuloglu M, Karaoglu A, Atmaca M, Ozkan Y, Tezcan EA. Psychiatric Symptoms InPatients with Type II Diabetes And Blood Glucose Control.Dusunen Adam. 2000; 13: 19-23.

22. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing Psychosocial Distress in Diabetes, Development of the Diabetes Distress Scale. Diabetes Care. 2005; 28: 626-31.

23. Fisher L, Glasgow RE, Mullan JT, Skaff MM, PolonskyWH.Development of a Brief Diabetes Distress Screening Instrument.Annals FamMed. 2008; 6: 246-52.

24. Citil R, Gunay O, Elmali F, OzturkY.Impact on Quality of Life Medical and Social Factors in Patients with Diabetes.Erciyes Tip Dergisi. 2010; 32: 253-64.

25. Society of Endocrinology and Metabolism of Turkey. Metabolic Syndrome Manual. [Online] 2009 [cited 2012 july 22].Available from: URL: http: //www.turkendokrin.org/files/pdf/metabolik_sendrom.pdf
COPYRIGHT 2016 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Journal of Pakistan Medical Association
Date:Jun 30, 2016
Words:2806
Previous Article:Evaluation of phenotypic tests for detection of Amp C beta-lactamases in clinical isolates from a tertiary care hospital of Rawalpindi, Pakistan.
Next Article:Serum myeloperoxidase (MPO) activity, oxidative and antioxidative parameters in operating room personnel.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |